Literature DB >> 2170142

Computer quantitation of gallium 67 lung uptake in crocidolite (blue asbestos) workers of Western Australia.

A A Hayes1, G W Thickbroom, G R Guelfi, A W Musk, A A van der Schaaf.   

Abstract

Pulmonary inflammation has been evaluated in 43 crocidolite-exposed asbestos (ASB) workers and 12 control subjects, using a quantitative index of gallium uptake (GI). The GI was compared with chest roentgenographs (CXRs) graded by the ILO classification. The ASB workers included 15 with asbestosis (CXR greater than or equal to 1/0), 19 with a normal CXR (CXR 0/0), and 9 with equivocal CXR changes (CXR 0/1). In individuals with asbestosis the GI was 3.6 +/- 0.3 (mean +/- SEM), P less than 0.01 compared with exposed patients without asbestosis. In exposed patients with equivocal CXR changes (0/1) the GI was 3.1 +/- 0.3, and in exposed patients with a normal CXR (0/0) the GI was 2.4 +/- 0.2. The GI for subjects without lung disease was 1.2 +/- 0.2, P less than 0.01 compared with exposed patients without asbestosis. The scans were scored independently by two observers, and the correlation coefficient of the two sets of GI was 0.95. These data demonstrate that subjects with crocidolite-induced asbestosis and exposed patients with equivocal CXR changes or a normal CXR have significantly increased GI.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170142     DOI: 10.1007/BF01280251

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  16 in total

1.  Predictions of future cases of asbestos-related disease among former miners and millers of crocidolite in Western Australia.

Authors:  N H de Klerk; B K Armstrong; A W Musk; M S Hobbs
Journal:  Med J Aust       Date:  1989 Dec 4-18       Impact factor: 7.738

2.  Prevalence of radiographic asbestosis in crocidolite miners and millers at Wittenoom, Western Australia.

Authors:  W O Cookson; N H De Klerk; A W Musk; B K Armstrong; J J Glancy; M S Hobbs
Journal:  Br J Ind Med       Date:  1986-07

3.  Scintiscanning of pulmonary diseases with 67Ga-citrate.

Authors:  F Kinoshita; T Ushio; A Maekawa; R Ariwa; A Kubo
Journal:  J Nucl Med       Date:  1974-04       Impact factor: 10.057

4.  Interpretation of the 67 Ga photoscan.

Authors:  S M Larson; M S Milder; G S Johnston
Journal:  J Nucl Med       Date:  1973-04       Impact factor: 10.057

5.  Computer-based quantitative analysis of gallium-67 uptake in normal and diseased lungs.

Authors:  G Bisson; G Drapeau; G Lamoureux; A Cantin; M Rola-Pleszczynski; R Bégin
Journal:  Chest       Date:  1983-11       Impact factor: 9.410

6.  Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history.

Authors:  A Miller; J C Thornton; R Warshaw; H Anderson; A S Teirstein; I J Selikoff
Journal:  Am Rev Respir Dis       Date:  1983-03

Review 7.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy.

Authors:  R G Crystal; J E Gadek; V J Ferrans; J D Fulmer; B R Line; G W Hunninghake
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

8.  Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation and physiologic and morphologic features and bronchoalveolar lavage.

Authors:  B R Line; J D Fulmer; H Y Reynolds; W C Roberts; A E Jones; E K Harris; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1978-08

9.  Computer-assisted versus visual lung gallium-67 index in normal subjects and in patients with interstitial lung disorders.

Authors:  L J Wesselius; K F Witztum; A T Taylor; M T Hartman; K M Moser
Journal:  Am Rev Respir Dis       Date:  1983-12

Review 10.  Quantitative gallium 67 lung scan to assess the inflammatory activity in the pneumoconioses.

Authors:  G Bisson; G Lamoureux; R Bégin
Journal:  Semin Nucl Med       Date:  1987-01       Impact factor: 4.446

View more
  2 in total

1.  Absolute quantitation of gallium-67 citrate accumulation in the lungs and its importance for the evaluation of disease activity in pulmonary sarcoidosis.

Authors:  M Myslivecek; V Husák; V Kolek; M Budíková; P Koranda
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Molecular Imaging of Pulmonary Inflammation and Infection.

Authors:  Chiara Giraudo; Laura Evangelista; Anna Sara Fraia; Amalia Lupi; Emilio Quaia; Diego Cecchin; Massimiliano Casali
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.